Synonyms: GC1008 | PET1073G12 [1]
Compound class:
Antibody
Comment: Fresolimumab is a monoclonal antibody targeting all isoforms of transforming growth factor beta (TGF-β1, -β2 and -β3.).
Annotated peptide sequence information for this antibody is available from its IMGT/mAb-DB link. BLAST peptide sequence analysis reveals patent US7723486 as the covering document for fresolimumab [1]. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
9158 | fresolimumab |
Synonyms ![]() |
|
GC1008 | PET1073G12 [1] |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 174 |
Other databases | |
GtoPdb PubChem SID | 252166476 |
Search PubMed clinical trials | fresolimumab |
Search PubMed titles | fresolimumab |
Search PubMed titles/abstracts | fresolimumab |
Wikipedia | Fresolimumab |